Serdar Bedii Omay

752 total citations
41 papers, 611 citations indexed

About

Serdar Bedii Omay is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Serdar Bedii Omay has authored 41 papers receiving a total of 611 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Hematology and 8 papers in Oncology. Recurrent topics in Serdar Bedii Omay's work include Retinoids in leukemia and cellular processes (4 papers), Ubiquitin and proteasome pathways (4 papers) and Cytokine Signaling Pathways and Interactions (3 papers). Serdar Bedii Omay is often cited by papers focused on Retinoids in leukemia and cellular processes (4 papers), Ubiquitin and proteasome pathways (4 papers) and Cytokine Signaling Pathways and Interactions (3 papers). Serdar Bedii Omay collaborates with scholars based in Türkiye, Japan and Kuwait. Serdar Bedii Omay's co-authors include Güray Saydam, Mehmet Sönmez, Ercüment Ovalı, Hikmet Hakan Aydın, Mustafa Yılmaz, Ender Terzıoğlu, Fahri Şahin, Elif Akdoğan, Rüçhan Uslu and Gülperi Öktem and has published in prestigious journals such as FEBS Letters, Food and Chemical Toxicology and Thrombosis and Haemostasis.

In The Last Decade

Serdar Bedii Omay

39 papers receiving 594 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Serdar Bedii Omay Türkiye 17 203 149 138 58 55 41 611
Ying Di United Kingdom 16 294 1.4× 138 0.9× 173 1.3× 41 0.7× 43 0.8× 33 654
Lisa M. Chelstrom United States 16 272 1.3× 125 0.8× 181 1.3× 47 0.8× 56 1.0× 33 907
Eri Yamamoto Japan 19 255 1.3× 75 0.5× 162 1.2× 26 0.4× 62 1.1× 45 773
J. K. Christman United States 9 645 3.2× 102 0.7× 120 0.9× 43 0.7× 55 1.0× 11 866
Bing Zheng China 21 364 1.8× 98 0.7× 343 2.5× 48 0.8× 51 0.9× 51 1.1k
J.R. Bertino United States 16 462 2.3× 105 0.7× 221 1.6× 69 1.2× 55 1.0× 28 925
Ruth Ann Henriksen United States 14 200 1.0× 177 1.2× 51 0.4× 35 0.6× 56 1.0× 29 643
Giulia Porro Italy 6 574 2.8× 100 0.7× 152 1.1× 25 0.4× 49 0.9× 10 783
C Mizon France 16 407 2.0× 103 0.7× 64 0.5× 45 0.8× 31 0.6× 39 811
Tsuyako Saito Japan 10 356 1.8× 77 0.5× 191 1.4× 53 0.9× 41 0.7× 37 722

Countries citing papers authored by Serdar Bedii Omay

Since Specialization
Citations

This map shows the geographic impact of Serdar Bedii Omay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serdar Bedii Omay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serdar Bedii Omay more than expected).

Fields of papers citing papers by Serdar Bedii Omay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Serdar Bedii Omay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serdar Bedii Omay. The network helps show where Serdar Bedii Omay may publish in the future.

Co-authorship network of co-authors of Serdar Bedii Omay

This figure shows the co-authorship network connecting the top 25 collaborators of Serdar Bedii Omay. A scholar is included among the top collaborators of Serdar Bedii Omay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Serdar Bedii Omay. Serdar Bedii Omay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Omay, Serdar Bedii, et al.. (2025). AML-364: Gilteritinib Experience in Relapsed/Refractory FLT3-Mutated AML Patients After Allogeneic Transplant: Two Cases. Clinical Lymphoma Myeloma & Leukemia. 25. S418–S418.
2.
Akdoğan, Elif, et al.. (2013). Evaluation of protein tyrosine phosphatase activity in patients with acute leukemia. Współczesna Onkologia. 1(1). 83–87. 1 indexed citations
3.
Sönmez, Mehmet, Mehmet Arslan, Ümit Çobanoğlu, et al.. (2009). Association of Gastrointestinal Stromal Tumor and Acute Myeloid Leukemia Preceded by Myelodysplastic Syndrome with Refractory Anemia. Tumori Journal. 95(2). 240–242. 5 indexed citations
4.
Yılmaz, Mustafa, Ahmet Durmuş, Mehmet Sönmez, et al.. (2009). The effects of electromagnetic fields on peripheral blood mononuclear cells in vitro.. PubMed. 110(9). 526–9. 11 indexed citations
5.
Sönmez, Mehmet, Ercüment Ovalı, Mustafa Yılmaz, et al.. (2007). The role of hepatocyte growth factor in the differentiation of dendritic cells from peripheral blood monocytes.. PubMed. 28(5). 688–95. 2 indexed citations
6.
Şahin, Fahri, Çığır Biray Avcı, Ferit Avcu, et al.. (2007). Red grape seed extract and its compound resveratrol exert cytotoxic effect to various human cancer lines.. PubMed. 24(3). 102–9. 5 indexed citations
7.
Sönmez, Mehmet, et al.. (2007). Change of coagulation parameters after double plateletpheresis. Transfusion and Apheresis Science. 37(2). 161–163. 15 indexed citations
8.
Sönmez, Mehmet, Kemalettin Aydın, Ahmet Durmuş, et al.. (2007). Plasma activity of thrombin activatable fibrinolysis inhibitor in Crimean-Congo hemorrhagic fever. Journal of Infection. 55(2). 184–187. 17 indexed citations
9.
Gündüz, Cumhur, Buket Kosova, Zühal Eroğlu, et al.. (2005). Evaluation of Manisa propolis effect on leukemia cell line by telomerase activity. Leukemia Research. 29(11). 1343–1346. 35 indexed citations
10.
Uslu, Rüçhan, Yalım Dikmen, Bülent Karabulut, et al.. (2005). Predictive value of serum interleukin-8 levels in ovarian cancer patients treated with paclitaxel-containing regimens. International Journal of Gynecological Cancer. 15(2). 240–245. 24 indexed citations
11.
Aydın, Hikmet Hakan, Hakan Kültürsay, Sabire Karaçalı, et al.. (2004). Induction of apoptosis by fatty acid ethyl esters in HepG2 cells. Food and Chemical Toxicology. 43(1). 139–145. 24 indexed citations
12.
Saydam, Güray, Hikmet Hakan Aydın, Fahri Şahin, et al.. (2003). Involvement of protein phosphatase 2A in interferon-α-2b-induced apoptosis in K562 human chronic myelogenous leukaemia cells. Leukemia Research. 27(8). 709–717. 45 indexed citations
13.
Saydam, Güray, et al.. (2002). Arsenic trioxide and methylprednisolone use different signal transduction pathways in leukemic differentiation. Leukemia Research. 26(4). 391–398. 21 indexed citations
14.
Şanlı, Ulus Ali, Rüçhan Uslu, Bülent Karabulut, et al.. (2002). Which dosing scheme is suitable for the taxanes? anin vitro model. Archives of Pharmacal Research. 25(4). 550–555. 5 indexed citations
15.
Sağcan, Abdi, et al.. (2002). The effect of type II diabetes mellitus on platelet aggregation in patients who underwent percutaneous transluminal coronary angioplasty. Coronary Artery Disease. 13(1). 45–48. 3 indexed citations
16.
Saydam, Güray, et al.. (2002). Acral Sclerosis due to Interferon-Alpha-2b in Chronic Myelogenous Leukemia. Acta Haematologica. 107(1). 43–45. 1 indexed citations
17.
18.
Omay, Serdar Bedii, Hitoshi Ogasawara, Hideki Toyoda, et al.. (1995). Translocation of protein phosphatase 1 catalytic subunits during 1,25-dihydroxyvitamin D3-induced monocytic differentiation of HL-60 cells.. PubMed. 55(4). 774–80. 21 indexed citations
19.
Kobayashi, Kazuhiko, Masakatsu Nishikawa, Serdar Bedii Omay, et al.. (1994). Forskolin potentiates G-CSF-induced proliferation of a murine myeloblastic leukemia cell line. Leukemia Research. 18(2). 111–117. 3 indexed citations
20.
Tawara, Isao, Masakatsu Nishikawa, Kazuhiko Kobayashi, et al.. (1993). Down‐regulation by retinoic acid of the catalytic subunit of protein phosphatase type 2A during granulocytic differentiation of HL‐60 cells. FEBS Letters. 321(2-3). 224–228. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ying Di Breakdown of academic impact, for papers by Lisa M. Chelstrom Breakdown of academic impact, for papers by Eri Yamamoto Breakdown of academic impact, for papers by J. K. Christman Breakdown of academic impact, for papers by Bing Zheng Breakdown of academic impact, for papers by J.R. Bertino Breakdown of academic impact, for papers by Ruth Ann Henriksen Breakdown of academic impact, for papers by Giulia Porro Breakdown of academic impact, for papers by C Mizon Breakdown of academic impact, for papers by Tsuyako Saito
Rankless by CCL
2026